Overview: Aromasin 25mg contains Exemestane, an irreversible steroidal aromatase inactivator indicated for the adjuvant treatment of postmenopausal women with estrogen receptor-positive early breast cancer. It functions through barrier fortification against estrogen synthesis by permanently binding to the aromatase enzyme, preventing the conversion of androgens into estrogens.

Dosage & Administration

• Dosage: 1 tablet (25mg) per administration.
• Frequency: Once daily.
• Method: Administer orally with 200ml of water. Swallow the tablet whole.
• Timing: Administer after a meal to ensure optimal pharmacological absorption and bioavailability.
• Duration: Use as directed by an oncologist, typically following 2-3 years of Tamoxifen therapy for a completed sequential hormonal regimen.

Safety & Storage

• Storage: Store at controlled room temperature below 30°C. Keep in original packaging to protect from environmental moisture.
• Warning: May cause a reduction in bone mineral density (BMD). Routine monitoring of Vitamin D levels and bone density is recommended during prolonged physiological support.